Press "Enter" to skip to content

U.S. Will Make Millions of Bird Flu Vaccines This Summer + More

The Defender’s Big Pharma Watch delivers the latest headlines related to pharmaceutical companies and their products, including vaccines, drugs, and medical devices and treatments. The views expressed in the below excerpts from other news sources do not necessarily reflect the views of The Defender. Our goal is to provide readers with breaking news that affects human health and the environment.

 

U.S. Will Make Millions of Bird Flu Vaccines This Summer

Medical Xpress reported:

As the H5N1 avian flu continues to spread among dairy cows in the United States, nearly 5 million doses of flu vaccine are now being prepared for possible use in humans.

Since the outbreak in livestock began this spring, bird flu has been confirmed in three humans who worked on dairy farms in Texas and Michigan and health experts are concerned the virus could mutate to the point where it could spread easily among humans.

In response, vaccine maker CSL Seqirus announced last week that it has been tasked with making additional doses of flu vaccine at its North Carolina plant. “It utilizes a highly scalable method of production and is currently positioned to deliver up to 150 million influenza vaccine doses to support an influenza pandemic response within six months of a pandemic declaration,” the company noted in a news release.

The new vaccine doses combine an antigen that targets the H5 portion of the H5N1 virus with an ingredient designed to boost the immune response triggered by the vaccine.

Read Full Article Here…(childrenshealthdefense.org)


Home | Caravan to Midnight (zutalk.com)

Live Stream + Chat (zutalk.com)

We Need Your Help to Keep Caravan To Midnight Going,

Please Consider Donating to Help Keep Independent Media Independent

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Breaking News: